Chinese herbal medicine (JianPi-BuShen) and completion rate of adjuvant chemotherapy for patients with stage II and III colon cancer: A randomized clinical trial
European Journal of Cancer · 2024-12 · 213 · 115109
DOI: 10.1016/j.ejca.2024.115109 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Cancer, 2024-12. Verfasst von Lingyun Sun und 31 weiteren Autor:innen. Beteiligte Einrichtung: Xiyuan Hospital, China Academy of Chinese Medical Sciences, China. Electronic address: slyslysun@126.com. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Colonic Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Staging. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xiyuan Hospital, China Academy of Chinese Medical Sciences, China. Electronic address: slyslysun@126.com.
- Xiyuan Hospital, China Academy of Chinese Medical Sciences, China.
- Beijing Cancer Hospital, China.
- Tianjin People's Hospital, China.
- Beijing University of Chinese Medicine, China.
- Jaingsu Provincial TCM Hospital, China.
Förderung
- NCI NIH HHS
Zitieren
APA
Sun, L., Xu, Y., Chen, N., Zhang, C., Wu, A., Wang, H., Fei, Y., Shu, P., Diao, D., Cheng, J., Chu, Y., Liu, T., Wang, W., Yuan, Y., Zeng, B., Cao, Y., Cang, S., Cao, H., Zhang, T., …, & Yang, Y. (2024). Chinese herbal medicine (JianPi-BuShen) and completion rate of adjuvant chemotherapy for patients with stage II and III colon cancer: A randomized clinical trial. European Journal of Cancer, 213, 115109. https://doi.org/10.1016/j.ejca.2024.115109
Vancouver
Sun L, Xu Y, Chen N, Zhang C, Wu A, Wang H, et al. Chinese herbal medicine (JianPi-BuShen) and completion rate of adjuvant chemotherapy for patients with stage II and III colon cancer: A randomized clinical trial. European Journal of Cancer. 2024;213:115109. doi:10.1016/j.ejca.2024.115109
BibTeX
@article{Sun2024,
author = {Sun, Lingyun and Xu, Yun and Chen, Nan and Zhang, Chunze and Wu, Aiwen and Wang, Huaqing and Fei, Yutong and Shu, Peng and Diao, Dechang and Cheng, Jianping and Chu, Yuping and Liu, Tianshu and Wang, Wei and Yuan, Ye and Zeng, Baozhu and Cao, Yang and Cang, Shundong and Cao, Huijuan and Zhang, Tong and Zheng, Yang and Wu, Cun'en and Liu, Shaoyong and He, Bin and Yan, Yunzi and Yan, Shaohua and Wu, Na and Ning, Chunhui and Peng, Rongyan and Epstein, Andrew S and Cytryn, Samuel and Mao, Jun J and Yang, Yufei},
title = {Chinese herbal medicine (JianPi-BuShen) and completion rate of adjuvant chemotherapy for patients with stage II and III colon cancer: A randomized clinical trial},
journal = {European Journal of Cancer},
year = {2024},
volume = {213},
pages = {115109},
doi = {10.1016/j.ejca.2024.115109}
}
EUVIMED